| 000 | 01381 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517110309.0 | ||
| 264 | 0 | _c20180112 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-16-1401 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGettinger, Scott | |
| 245 | 0 | 0 |
_aPD-1 Axis Inhibitors in EGFR- and ALK-Driven Lung Cancer: Lost Cause? _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cSep 2016 |
||
| 300 |
_a4539-41 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAnaplastic Lymphoma Kinase |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aErbB Receptors _xgenetics |
| 650 | 0 | 4 | _aGene Rearrangement |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xgenetics |
| 650 | 0 | 4 |
_aTumor Microenvironment _xdrug effects |
| 700 | 1 | _aPoliti, Katerina | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 22 _gno. 18 _gp. 4539-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-16-1401 _zAvailable from publisher's website |
| 999 |
_c26277637 _d26277637 |
||